E. Jermann

1.2k total citations
11 papers, 985 citations indexed

About

E. Jermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Genetics. According to data from OpenAlex, E. Jermann has authored 11 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Epidemiology and 2 papers in Genetics. Recurrent topics in E. Jermann's work include Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (6 papers) and Medical Imaging Techniques and Applications (3 papers). E. Jermann is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Neuroendocrine Tumor Research Advances (6 papers) and Medical Imaging Techniques and Applications (3 papers). E. Jermann collaborates with scholars based in Switzerland, Italy and Sweden. E. Jermann's co-authors include Martin Béhé, Helmut R. Mäcke, P. Powell, A. Heppeler, Michael Hennig, Sylvie Froidevaux, Helmut R. Maëcke, Andreas Otte, Jan Mueller‐Brand and Willem H. Bakker and has published in prestigious journals such as Scientific Reports, Chemistry - A European Journal and International Journal of Cancer.

In The Last Decade

E. Jermann

11 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Jermann Switzerland	9	581	513	448	303	104	11	985
Dariusz Pawlak Poland	20	716 1.2×	660 1.3×	664 1.5×	436 1.4×	268 2.6×	65	1.3k
Jan‐Erik Westlin Sweden	14	524 0.9×	283 0.6×	449 1.0×	278 0.9×	356 3.4×	36	1.1k
Josef Doll Germany	11	502 0.9×	273 0.5×	192 0.4×	130 0.4×	114 1.1×	13	752
M. Leimer Austria	18	311 0.5×	522 1.0×	426 1.0×	261 0.9×	77 0.7×	26	871
Jörg Schmitt Switzerland	8	623 1.1×	1.0k 2.0×	807 1.8×	541 1.8×	99 1.0×	10	1.4k
P. Powell Switzerland	8	538 0.9×	361 0.7×	354 0.8×	166 0.5×	104 1.0×	8	793
Stefan Guhlke Germany	21	833 1.4×	720 1.4×	889 2.0×	501 1.7×	333 3.2×	55	1.6k
Paola Rocca Italy	9	296 0.5×	460 0.9×	392 0.9×	303 1.0×	68 0.7×	10	750
Stefania Zoboli Italy	9	374 0.6×	483 0.9×	427 1.0×	315 1.0×	61 0.6×	12	831
Frederik Cleeren Belgium	20	721 1.2×	248 0.5×	474 1.1×	158 0.5×	147 1.4×	47	1.2k

Countries citing papers authored by E. Jermann

Since Specialization

Citations

This map shows the geographic impact of E. Jermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Jermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Jermann more than expected).

Fields of papers citing papers by E. Jermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Jermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Jermann. The network helps show where E. Jermann may publish in the future.

Co-authorship network of co-authors of E. Jermann

This figure shows the co-authorship network connecting the top 25 collaborators of E. Jermann. A scholar is included among the top collaborators of E. Jermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Jermann. E. Jermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Polikarpov, Maxim, Joan Vila‐Comamala, Zhentian Wang, et al.. (2023). Towards virtual histology with X-ray grating interferometry. Scientific Reports. 13(1). 9049–9049. 7 indexed citations

Cremonesi, Marta, Mahila Ferrari, Stefania Zoboli, et al.. (1999). Biokinetics and dosimetry in patients administered with 111 In-DOTA-Tyr 3 -octreotide: implications for internal radiotherapy with 90 Y-DOTATOC. European Journal of Nuclear Medicine and Molecular Imaging. 26(8). 877–886. 118 indexed citations

Riva, Paola, G. Franceschi, M. Frattarelli, et al.. (1999). Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study.. PubMed. 5(10 Suppl). 3275s–3280s. 61 indexed citations

Heppeler, A., Sylvie Froidevaux, Helmut R. Mäcke, et al.. (1999). Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy. Chemistry - A European Journal. 5(7). 1974–1981. 287 indexed citations

Merlo, Adrian, Oliver Hausmann, Andreas Otte, et al.. (1999). Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.. PubMed. 5(5). 1025–33. 76 indexed citations

Heppeler, A., Helmut R. Mäcke, E. Jermann, et al.. (1999). Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy. Chemistry - A European Journal. 5(7). 1974–1981. 9 indexed citations

Otte, Andreas, E. Jermann, Martin Béhé, et al.. (1997). DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 792–795. 171 indexed citations

Jong, Marion de, Willem H. Bakker, Eric P. Krenning, et al.. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 24(4). 368–371. 173 indexed citations

Merlo, Adrian, E. Jermann, Oliver Hausmann, et al.. (1997). Biodistribution of 111In‐labelled SCN‐bz‐DTPA‐BC‐2 MAb following loco‐regional injection into glioblastomas. International Journal of Cancer. 71(5). 810–816. 4 indexed citations

10.

Jong, Marion de, Willem H. Bakker, Eric P. Krenning, et al.. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA 0 , d -Phe 1 ,Tyr 3 ]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 24(4). 368–371. 54 indexed citations

11.

Merlo, Adrian, E. Jermann, Oliver Hausmann, et al.. (1997). Biodistribution of111In-labelled SCN-bz-DTPA-BC-2 MAb following loco-regional injection into glioblastomas. International Journal of Cancer. 71(5). 810–816. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact